Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Noncash or Part Noncash Acquisition, Fixed Assets Acquired

2.0 / 5 stars · 40/98 Roast Me

PROTHENA CORPORATION PUBLIC LIMITED COMPANY Noncash or Part Noncash Acquisition, Fixed Assets Acquired

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $76.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-08-06

  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-06-30 was $76.00K.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-09-30 was -$7.00K.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $75.00K, a 68.35% decline from fiscal 2023.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $237.00K.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY noncash or part noncash acquisition, fixed assets acquired for fiscal 2022 was $0.00.
Period endNoncash or Part Noncash Acquisition, Fixed Assets Acquired 3 monthNoncash or Part Noncash Acquisition, Fixed Assets Acquired 6 monthNoncash or Part Noncash Acquisition, Fixed Assets Acquired 9 monthNoncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month
2026-06-30$76.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$76.00K
10-Q · filed 2026-08-06
$76.00K
derived: sum of 3 quarters · filed 2026-08-06
$69.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$0.00
10-Q · filed 2026-05-07
$0.00
derived: sum of 2 quarters · filed 2026-05-07
-$7.00K
derived: sum of 3 quarters · filed 2026-05-07
-$49.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$7.00K
derived: sum of 2 quarters · filed 2026-02-27
-$49.00K
derived: sum of 3 quarters · filed 2026-08-06
$0.00
10-K · filed 2026-02-27
2025-09-30-$7.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$49.00K
derived: sum of 2 quarters · filed 2026-08-06
$0.00
10-Q · filed 2025-11-06
$4.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$42.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$7.00K
10-Q · filed 2026-08-06
$11.00K
derived: sum of 3 quarters · filed 2026-08-06
-$4.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$49.00K
10-Q · filed 2026-05-07
$53.00K
derived: sum of 2 quarters · filed 2026-05-07
$38.00K
derived: sum of 3 quarters · filed 2026-05-07
-$60.00K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$4.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$11.00K
derived: sum of 2 quarters · filed 2026-02-27
-$109.00K
derived: sum of 3 quarters · filed 2026-02-27
$75.00K
10-K · filed 2026-02-27
2024-09-30-$15.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$113.00K
derived: sum of 2 quarters · filed 2025-11-06
$71.00K
10-Q · filed 2025-11-06
$215.00K
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30-$98.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04
$86.00K
10-Q · filed 2025-08-04
$230.00K
derived: sum of 3 quarters · filed 2026-02-27
$280.00K
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$184.00K
10-Q · filed 2025-05-08
$328.00K
derived: sum of 2 quarters · filed 2026-02-27
$378.00K
derived: sum of 3 quarters · filed 2026-02-27
$76.00K
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$144.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$194.00K
derived: sum of 2 quarters · filed 2026-02-27
-$108.00K
derived: sum of 3 quarters · filed 2026-02-27
$237.00K
10-K · filed 2026-02-27
2023-09-30$50.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$252.00K
derived: sum of 2 quarters · filed 2024-11-12
$93.00K
10-Q · filed 2024-11-12
-$127.00K
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$302.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$43.00K
10-Q · filed 2024-08-08
-$177.00K
derived: sum of 3 quarters · filed 2025-02-27
$11.00K
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$345.00K
10-Q · filed 2024-05-08
$125.00K
derived: sum of 2 quarters · filed 2025-02-27
$313.00K
derived: sum of 3 quarters · filed 2025-02-27
$332.00K
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$220.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$32.00K
derived: sum of 2 quarters · filed 2025-02-27
-$13.00K
derived: sum of 3 quarters · filed 2025-02-27
$0.00
10-K · filed 2025-02-27
2022-09-30$188.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$207.00K
derived: sum of 2 quarters · filed 2023-11-02
$220.00K
10-Q · filed 2023-11-02
$209.00K
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$19.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$32.00K
10-Q · filed 2023-08-03
$21.00K
derived: sum of 3 quarters · filed 2024-02-22
-$44.00K
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$13.00K
10-Q · filed 2023-05-04
$2.00K
derived: sum of 2 quarters · filed 2024-02-22
-$63.00K
derived: sum of 3 quarters · filed 2024-02-22
$13.00K
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$11.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$76.00K
derived: sum of 2 quarters · filed 2024-02-22
$0.00
derived: sum of 3 quarters · filed 2024-02-22
$0.00
10-K · filed 2024-02-22
2021-09-30-$65.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$11.00K
derived: sum of 2 quarters · filed 2022-11-03
$11.00K
10-Q · filed 2022-11-03
-$26.00K
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$76.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$76.00K
10-Q · filed 2022-08-08
$39.00K
derived: sum of 3 quarters · filed 2022-08-08
$33.00K
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31$0.00
10-Q · filed 2022-05-05
-$37.00K
derived: sum of 2 quarters · filed 2022-05-05
-$43.00K
derived: sum of 3 quarters · filed 2022-05-05
-$24.00K
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-$37.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$43.00K
derived: sum of 2 quarters · filed 2022-02-25
-$24.00K
derived: sum of 3 quarters · filed 2022-02-25
$0.00
10-K · filed 2022-02-25
2020-09-30-$6.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$13.00K
derived: sum of 2 quarters · filed 2021-11-04
$37.00K
10-Q · filed 2021-11-04
-$40.00K
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$19.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$43.00K
10-Q · filed 2021-08-05
-$34.00K
derived: sum of 3 quarters · filed 2022-02-25
$36.00K
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$24.00K
10-Q · filed 2021-05-11
-$53.00K
derived: sum of 2 quarters · filed 2022-02-25
$17.00K
derived: sum of 3 quarters · filed 2022-02-25
$21.00K
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31-$77.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$7.00K
derived: sum of 2 quarters · filed 2022-02-25
-$3.00K
derived: sum of 3 quarters · filed 2022-02-25
$5.00K
10-K · filed 2022-02-25
2019-09-30$70.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
$74.00K
derived: sum of 2 quarters · filed 2020-11-04
$82.00K
10-Q · filed 2020-11-04
-$23.00K
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$4.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$12.00K
10-Q · filed 2020-08-06
-$93.00K
derived: sum of 3 quarters · filed 2021-02-26
$102.00K
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$8.00K
10-Q · filed 2020-05-06
-$97.00K
derived: sum of 2 quarters · filed 2021-02-26
$98.00K
derived: sum of 3 quarters · filed 2021-02-26
$19.00K
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31-$105.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$90.00K
derived: sum of 2 quarters · filed 2021-02-26
$11.00K
derived: sum of 3 quarters · filed 2021-02-26
$90.00K
10-K · filed 2021-02-26
2018-09-30$195.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$116.00K
derived: sum of 2 quarters · filed 2019-11-05
$195.00K
10-Q · filed 2019-11-05
$207.00K
derived: sum of 4 quarters · filed 2020-03-03
2018-06-30-$79.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$0.00
10-Q · filed 2019-08-06
$12.00K
derived: sum of 3 quarters · filed 2020-03-03
-$218.00K
derived: sum of 4 quarters · filed 2020-03-03
2018-03-31$79.00K
10-Q · filed 2019-05-07
$91.00K
derived: sum of 2 quarters · filed 2020-03-03
-$139.00K
derived: sum of 3 quarters · filed 2020-03-03
$166.00K
derived: sum of 4 quarters · filed 2020-03-03
2017-12-31$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03
-$218.00K
derived: sum of 2 quarters · filed 2020-03-03
$87.00K
derived: sum of 3 quarters · filed 2020-03-03
$175.00K
10-K · filed 2020-03-03
2017-09-30-$230.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$75.00K
derived: sum of 2 quarters · filed 2018-11-06
$163.00K
10-Q · filed 2018-11-06
-$3.34M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30$305.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$393.00K
10-Q · filed 2018-08-07
-$3.11M
derived: sum of 3 quarters · filed 2019-03-15
$952.00K
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31$88.00K
10-Q · filed 2018-05-09
-$3.41M
derived: sum of 2 quarters · filed 2019-03-15
$647.00K
derived: sum of 3 quarters · filed 2019-03-15
$403.00K
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31-$3.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
$559.00K
derived: sum of 2 quarters · filed 2019-03-15
$315.00K
derived: sum of 3 quarters · filed 2019-03-15
$575.00K
10-K · filed 2019-03-15
2016-09-30$4.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$3.82M
derived: sum of 2 quarters · filed 2017-11-07
$4.08M
10-Q · filed 2017-11-07
$4.26M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30-$244.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$16.00K
10-Q · filed 2017-08-09
$201.00K
derived: sum of 3 quarters · filed 2018-02-26
$186.00K
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31$260.00K
10-Q · filed 2017-05-09
$445.00K
derived: sum of 2 quarters · filed 2018-02-26
$430.00K
derived: sum of 3 quarters · filed 2018-02-26
$445.00K
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$185.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$170.00K
derived: sum of 2 quarters · filed 2018-02-26
$185.00K
derived: sum of 3 quarters · filed 2018-02-26
$185.00K
10-K · filed 2018-02-26
2015-09-30-$15.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$0.00
derived: sum of 2 quarters · filed 2016-11-02
$0.00
10-Q · filed 2016-11-02
2015-06-30$15.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02
$15.00K
10-Q · filed 2016-08-02
2015-03-31$0.00
10-Q · filed 2016-05-04
2014-12-31$0.00
10-K · filed 2017-02-27
2014-06-30-$10.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$0.00
10-Q · filed 2015-08-05
2014-03-31$10.00K
10-Q · filed 2015-05-06
2013-12-31$26.00K
10-K · filed 2016-02-25
2013-03-31$0.00
10-Q · filed 2014-05-05
2012-12-31$0.00
10-K · filed 2015-03-13
2011-12-31$0.00
10-K · filed 2014-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10